BE899293A - Compositions pharmaceutiques a liberation soutenue de theophylline. - Google Patents
Compositions pharmaceutiques a liberation soutenue de theophylline.Info
- Publication number
- BE899293A BE899293A BE0/212666A BE212666A BE899293A BE 899293 A BE899293 A BE 899293A BE 0/212666 A BE0/212666 A BE 0/212666A BE 212666 A BE212666 A BE 212666A BE 899293 A BE899293 A BE 899293A
- Authority
- BE
- Belgium
- Prior art keywords
- theophyllin
- pharmaceutical compositions
- sustained release
- release pharmaceutical
- theophylline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un granule à absorption soutenue de théophylline constitué d'un noyau de théophylline ou d'un équivalent pharmacologique de cette dernière et d'un acide organique noyé dans une matière polymère en couches multiples et d'une membrane externe qui permet la libération de la théophylline à vitesse réglée en milieu aqueux.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE789/83A IE55745B1 (en) | 1983-04-06 | 1983-04-06 | Sustained absorption pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BE899293A true BE899293A (fr) | 1984-07-16 |
Family
ID=11018164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/212666A BE899293A (fr) | 1983-04-06 | 1984-03-30 | Compositions pharmaceutiques a liberation soutenue de theophylline. |
Country Status (9)
Country | Link |
---|---|
US (2) | US4663150A (fr) |
EP (1) | EP0122077B1 (fr) |
JP (1) | JPS59219219A (fr) |
AT (1) | ATE53176T1 (fr) |
BE (1) | BE899293A (fr) |
CH (1) | CH660688B (fr) |
DE (1) | DE3482374D1 (fr) |
IE (1) | IE55745B1 (fr) |
PH (1) | PH18904A (fr) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
IE58246B1 (en) * | 1984-12-21 | 1993-08-11 | Byk Gulden Lomberg Chem Fab | Theophylline sustained release formulation |
GB2170104A (en) * | 1985-01-30 | 1986-07-30 | Warner Lambert Co | Coated pharmaceutical dosage forms |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5026709A (en) * | 1986-04-07 | 1991-06-25 | Rorer Pharmaceutical Corporation | Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby |
IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US5286494A (en) * | 1986-07-02 | 1994-02-15 | Schering Aktiengesellschaft | Medicinal agents with sustained action |
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
IL84599A0 (en) * | 1986-12-09 | 1988-04-29 | Byk Gulden Lomberg Chem Fab | Pharmaceutical composition containing urapidil and process for the preparation thereof |
US4789549A (en) * | 1987-03-09 | 1988-12-06 | Warner-Lambert Company | Sustained release dosage forms |
US4808413A (en) * | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
CA1323833C (fr) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Compositions pharmaceutiques sous forme de granules et methode de fabrication |
US4786509A (en) * | 1987-05-18 | 1988-11-22 | Schering Corporation | Dry sustained release theophylline oral formulation |
EP0856313A1 (fr) * | 1987-10-16 | 1998-08-05 | ELAN CORPORATION, Plc | Formulations de diltiazem à absorption contrÔlée |
IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
DE3929864A1 (de) * | 1989-09-08 | 1991-03-14 | Nordmark Arzneimittel Gmbh | Verfahren zur herstellung von theophyllin-pellets |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
US5162110A (en) * | 1990-12-19 | 1992-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Binding theophylline to ion exchange resins |
US5431922A (en) * | 1991-03-05 | 1995-07-11 | Bristol-Myers Squibb Company | Method for administration of buspirone |
WO1992020326A1 (fr) * | 1991-05-20 | 1992-11-26 | Marion Laboratories, Inc. | Composition multicouche a liberation regulee |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
US5744164A (en) * | 1994-12-16 | 1998-04-28 | Nestec S.A. | Sustained release microparticulate caffeine formulation |
US20030215507A1 (en) * | 1996-03-25 | 2003-11-20 | Wyeth | Extended release formulation |
US5766623A (en) * | 1996-03-25 | 1998-06-16 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Compactable self-sealing drug delivery agents |
US20060067999A1 (en) * | 1996-03-25 | 2006-03-30 | Wyeth | Extended release formulation |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US20040029959A1 (en) * | 2002-08-08 | 2004-02-12 | John Devane | Isosorbide mononitrate compositions and methods of their use |
WO2004022037A1 (fr) * | 2002-09-04 | 2004-03-18 | Ranbaxy Laboratories Limited | Formes dosifiees a gout masque, et leurs procedes de preparation |
GB0227948D0 (en) * | 2002-11-29 | 2003-01-08 | Cipla Ltd | Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
DE10353196A1 (de) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
EP1753405A4 (fr) * | 2004-06-10 | 2008-09-17 | Glatt Air Tech Inc | Preparation pharmaceutique a liberation lente |
BRPI0609598A2 (pt) * | 2005-03-29 | 2010-04-20 | Roehm Gmbh | forma farmacêutica multiparticulada compreendendo péletes com uma substáncia possuindo um efeito modular em relação à liberação de ingrediente ativo |
EP1743638A1 (fr) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Formulations pharmaceutiques des derivés de la pyrazoline |
AU2006269944A1 (en) * | 2005-07-19 | 2007-01-25 | Inverseon, Inc. | Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
BRPI0707324A2 (pt) * | 2006-01-27 | 2011-05-03 | Eurand Inc | sistemas de fornecimento de fármaco compreendendo agente de bloqueio de serotonina 5-ht3 seletivo fracamente básico e ácidos orgánicos |
CN101410093A (zh) * | 2006-01-27 | 2009-04-15 | 欧兰德股份有限公司 | 包含弱碱性药物和有机酸的药物递送系统 |
PL2051704T3 (pl) * | 2006-08-18 | 2012-09-28 | Evonik Roehm Gmbh | Kompozycja farmaceutyczna o kontrolowanym dostarczaniu substancji aktywnej o dobrej rozpuszczalności |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
US8992898B2 (en) | 2010-04-17 | 2015-03-31 | Shannon Elizabeth Klingman | Antiperspirants and deodorants |
CA2902911C (fr) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methodes et compositions destinees au traitement du trouble de deficit d'attention |
HUE053082T2 (hu) * | 2018-09-27 | 2021-06-28 | Inibsa Ginecologia S A | Eljárás doxilamin-szukcinát- és piridoxin-hidroklorid-tartalmú, módosított hatóanyag-leadású, több kis egységet tartalmazó, orális adagolási forma elõállítására |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2853420A (en) * | 1956-01-25 | 1958-09-23 | Lowey Hans | Ethyl cellulose coatings for shaped medicinal preparations |
US3081233A (en) * | 1960-08-08 | 1963-03-12 | Upjohn Co | Enteric-coated pilules |
NL270408A (fr) * | 1960-10-20 | |||
BE636568A (fr) * | 1961-01-31 | |||
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
NL297631A (fr) * | 1963-06-03 | |||
US3949068A (en) * | 1964-02-20 | 1976-04-06 | University Of Alabama In Birmingham Medical And Educational Foundation | Pharmaceutical compositions |
US3400185A (en) * | 1965-04-08 | 1968-09-03 | Bristol Myers Co | Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
DE2343218C2 (de) * | 1973-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | Furosemid enthaltende Pellets |
US3906087A (en) * | 1973-09-10 | 1975-09-16 | Union Corp | Sustained release of methantheline |
US4085214A (en) * | 1976-10-18 | 1978-04-18 | Interx Research Corporation | Stable pro-drug forms of theophylline |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
JPS56122311A (en) * | 1980-02-29 | 1981-09-25 | Eisai Co Ltd | Lasting theophylline pharmaceutical composition |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
WO1983000284A1 (fr) * | 1981-07-15 | 1983-02-03 | Key Pharma | Theophylline a liberation prolongee |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
-
1983
- 1983-04-06 IE IE789/83A patent/IE55745B1/en not_active IP Right Cessation
-
1984
- 1984-03-22 AT AT84301954T patent/ATE53176T1/de active
- 1984-03-22 EP EP84301954A patent/EP0122077B1/fr not_active Expired - Lifetime
- 1984-03-22 DE DE8484301954T patent/DE3482374D1/de not_active Expired - Fee Related
- 1984-03-30 BE BE0/212666A patent/BE899293A/fr not_active IP Right Cessation
- 1984-04-04 CH CH170584A patent/CH660688B/fr unknown
- 1984-04-05 PH PH30501A patent/PH18904A/en unknown
- 1984-04-06 JP JP59068974A patent/JPS59219219A/ja active Granted
-
1986
- 1986-05-21 US US06/870,293 patent/US4663150A/en not_active Expired - Lifetime
-
1987
- 1987-01-16 US US07/003,736 patent/US4820521A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CH660688B (fr) | 1987-06-15 |
EP0122077A2 (fr) | 1984-10-17 |
EP0122077A3 (en) | 1985-09-11 |
JPH0466207B2 (fr) | 1992-10-22 |
DE3482374D1 (de) | 1990-07-05 |
IE55745B1 (en) | 1991-01-02 |
PH18904A (en) | 1985-10-30 |
JPS59219219A (ja) | 1984-12-10 |
ATE53176T1 (de) | 1990-06-15 |
US4820521A (en) | 1989-04-11 |
US4663150A (en) | 1987-05-05 |
EP0122077B1 (fr) | 1990-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE899293A (fr) | Compositions pharmaceutiques a liberation soutenue de theophylline. | |
ES1031697Y (es) | Estructura para la construccion de casas destinadas para juegos infantiles. | |
DE69612432D1 (de) | Messung der Alkoholkonzentrationen in der Atemluft | |
BR9201207A (pt) | Sulfonilaminocarbonitriazolinonas com substituintes ligados sobre oxigeno,processo para sua preparacao,agente herbicida,emprego,processos para o combate de ervas daninhas e para a preparacao de agentes e triazolinonas | |
BR8700936A (pt) | Aparelhagem de fibra optica alongada e sistema sensor para sentir uma caracteristica especificada do conteudo de um fluido | |
IT8919730A0 (it) | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. | |
RU93004786A (ru) | Платформа | |
IT8403571A1 (it) | Dispositivo per misurare l'umidita' contenuta nella pelle o simili. | |
ES509085A0 (es) | "perfeccionamientos en la fabricacion de dispositivos de retencion axial para ejes cilindricos". | |
IT8723206A0 (it) | Sospensione per la ruota anteriore di motociclette e simili. | |
BR8501627A (pt) | Processos para preparacao de tartarato oticamente ativo de di-(3-cloro-2-oxi-propiltrimetilaminio),e cloreto nitrilico de carnitina oticamente ativo | |
ES513576A0 (es) | "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos". | |
FI833655A (fi) | Fog foer sammanfogning av traebalkar och fogens anvaendning vid takstolskonstruktionen. | |
ITRM910490A0 (it) | Struttura di fibre di rinforzo, da usare per la fabbricazione di travi, telai e simili | |
IT1231764B (it) | Composizione poliuretanica con capacita' di assorbire umidita', particolarmente adatta per la fabbricazione di cuoio sintetico e simili, e procedimento per la sua produzione. | |
DE69120257D1 (de) | Sphärische hydraulische substanz und ihre herstellung | |
DE69105966D1 (de) | Herstellung von sphärischen faseraggregat. | |
IT8805215A0 (it) | Girello per bambini con sistema di arresto in presenza di gradini o dislivelli. | |
ES535697A0 (es) | Perfeccionamientos en la fabricacion de microcapsulas | |
ES513956A0 (es) | "procedimiento para la carbonilacion de olefinas y esteres organicos". | |
ES508153A0 (es) | "perfeccionamientos introducidos en la estructura y fabricacion de bastidores para silenciador". | |
ES510647A0 (es) | "procedimiento para la preparacion de acido fluorhidrico y co y-o co2 a partir de compuestos organicos fluorados". | |
IT8522618A0 (it) | Sistema per la costruzione di dighe a scalini, a modo di gradinata e/o mosaico, ad uso ricreativo. | |
IT8912009A0 (it) | Sistema per ristabilire l'equilibrio marino mediante la coprecipitazione del fosforo e delle alghe | |
JPS6329106U (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: ELAN CORP. P.L.C. Effective date: 19990331 |